PDCD1 and neoplasm: On the one hand, tumor-infiltrating T cells are characterized by defects in oxidative metabolism, mitochondrial biogenesis and fusion, and it has been demonstrated that metabolic reprogramming of these cells improves response to PD-1 blockade [123].